Literature DB >> 9565577

Determination of interaction sites on the small G protein RhoA for phospholipase D.

C D Bae1, D S Min, I N Fleming, J H Exton.   

Abstract

Phospholipase D (PLD) has been identified as a target of small G proteins of the Rho family. The present study was directed at defining the interaction sites of RhoA with rat brain PLD in vitro using chimeric proteins between RhoA and Ha-Ras or Cdc42Hs and point mutations. The switch I region of RhoA, which is the common effector domain of Ras-like G proteins, was a crucial interaction site for PLD. Mutations in conserved amino acids (Tyr34, Thr37, Phe39) totally abolished PLD activation, while mutations in Val38 or Tyr42 caused partial loss. Two additional sites were responsible for the differential PLD activation ability between RhoA and Cdc42Hs. Changing Asp76 in the switch II region of RhoA to the corresponding amino acid in Cdc42Hs led to partial loss of PLD activation. A chimeric protein with the N-terminal third of Cdc42Hs changed to RhoA showed enhanced PLD activation. Analysis of other Rho/Ha-Ras chimeric proteins and mutations indicated that Gln52 adjacent to the switch II region is responsible for this gain of function. In conclusion, the present study shows that conserved amino acids in the switch I region of RhoA are major PLD interaction sites and that residues in the switch II and internal regions are responsible for the differential activation of PLD by RhoA and Cdc42Hs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9565577     DOI: 10.1074/jbc.273.19.11596

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.

Authors:  T Goi; G Rusanescu; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.

Authors:  Karen M Henkels; Hong-Juan Peng; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

4.  Dynamic properties of the Ras switch I region and its importance for binding to effectors.

Authors:  M Spoerner; C Herrmann; I R Vetter; H R Kalbitzer; A Wittinghofer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module.

Authors:  Matteo Bolomini-Vittori; Alessio Montresor; Cinzia Giagulli; Donald Staunton; Barbara Rossi; Marianna Martinello; Gabriela Constantin; Carlo Laudanna
Journal:  Nat Immunol       Date:  2009-01-11       Impact factor: 25.606

6.  Antimicrobial agent triclosan suppresses mast cell signaling via phospholipase D inhibition.

Authors:  Juyoung K Shim; Molly A Caron; Lisa M Weatherly; Logan B Gerchman; Suraj Sangroula; Siham Hattab; Alan Y Baez; Talya J Briana; Julie A Gosse
Journal:  J Appl Toxicol       Date:  2019-08-19       Impact factor: 3.446

7.  In search of the message.

Authors:  John H Exton
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

Review 8.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

9.  Determination of interaction sites of phospholipase D1 for RhoA.

Authors:  S Cai; J H Exton
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 10.  Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.

Authors:  Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.